
Sign up to save your podcasts
Or


In today’s episode on 21st July 2025, we follow a $2 billion cancer-drug deal, review India’s decades-old drug-manufacturing playbook, and ask whether an “America-first” clampdown could force domestic drugmakers to climb the value ladder faster than ever.
By Finshots4.9
3434 ratings
In today’s episode on 21st July 2025, we follow a $2 billion cancer-drug deal, review India’s decades-old drug-manufacturing playbook, and ask whether an “America-first” clampdown could force domestic drugmakers to climb the value ladder faster than ever.

296 Listeners

32 Listeners

1,649 Listeners

14 Listeners

176 Listeners

828 Listeners

289 Listeners

5 Listeners

5 Listeners

15 Listeners

688 Listeners

11 Listeners

94 Listeners

10 Listeners

30 Listeners